Relacorilant + Nab-Paclitaxel vs Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer: Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Exposure-Response
Presented: European Gynaecological Oncology Congress, 27 February 2026, Copenhagen, Denmark
Presenter: Nicoletta Colombo, M.D., Ph.D.
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.
